Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.

J, Xu; C, Wu; X, Che; L, Wang; D, Yu; T, Zhang; L, Huang; H, Li; W, Tan; C, Wang; D, Lin

doi:10.1002/mc.20712

Public

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.

Shared by NobleBlocks on Dec 10, 2010 • 12:00 AM UTC

Authors:

Xu J

Wu C

Che X

Abstract

Numerous studies have shown that aberrant microRNA (miRNA) expression is associated with the development and progression of various types of human cancer and serum miRNAs are potential biomarkers. This study examined whether some commonly deregulated miRNAs in hepatocellular carcinoma (HCC) are pres...

Discussions